Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|17|31|3328-3335

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.31, 2018-02, pp. : 3328-3335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Target-Directed Ligands in Alzheimer's Disease Treatment

By  

Current Medicinal Chemistry, Vol. 18, Iss. 32, 2011-11 ,pp. : 4949-4975

Bentham Science Publishers

Access to resources Recommend Favorite

New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3349-3360

Bentham Science Publishers

Access to resources Recommend Favorite

From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 960-967

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 27, 2017-11 ,pp. : 3000-3016

Bentham Science Publishers

Access to resources Recommend Favorite

Multitarget-Directed Ligands: Innovative Chemical Probes and Therapeutic Tools Against Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 22, 2011-11 ,pp. : 2797-2806

Bentham Science Publishers

Access to resources Recommend Favorite